Purpose
to use optogenetics in manufacturing of an RSV monoclonal antibody to reduce the cost of goods and make it affordable and accessible to vulnerable populations in low- and middle-income countries
Grantee
Division
Global Health
Date
JULY 2026
Region served
GLOBAL
Committed amount
$1,126,049
Grant topic
Discovery and Translational Sciences,
Vaccine Development
Duration (months)
11
Grantee location
Emeryville, California, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.